Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$11.19 - $16.92 $44,760 - $67,680
-4,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.62 - $4.29 $14,480 - $17,160
4,000 New
4,000 $17,000
Q2 2019

Aug 14, 2019

SELL
$3.59 - $4.3 $14,360 - $17,200
-4,000 Closed
0 $0
Q4 2018

May 23, 2019

BUY
$2.98 - $3.9 $11,920 - $15,600
4,000 New
4,000 $14,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $82.8M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.